Xuan Che

No ORCID on file · 16 papers in corpus · active 2012-2025

Study types

  • article 12
  • other 3
  • preprint 1

Condition tags

  • endometriosis 9
  • adenomyosis 9
  • mesh:D004715 6
  • dysmenorrhea 3
  • mesh:D004412 2
article 2025
Science China. Life sciences ·doi:10.1007/s11427-025-2981-1
other 2025
Scientific reports ·doi:10.1038/s41598-024-84608-5

This study aimed to elucidate the role of microRNA-92a-3p (miR-92a-3p) in the pathogenesis of adenomyosis. We examined how miR-92a-3p, found in exosomes derived from ectopic lesions, influences the behaviour of endometrial cells, dorsal roo…

other 2025
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.70111

AIM: This study aimed to compare clinical characteristics and evaluate diagnostic biomarkers in ovarian endometriosis, with a focus on thyroid autoimmunity associations. METHODS: A retrospective analysis of 885 patients (441 ovarian endome…

other 2024
Protein & cell ·doi:10.1093/procel/pwae012

Adenomyosis is a poorly understood gynecological disorder lacking effective treatments. Controversy persists regarding "invagination" and "metaplasia" theories. The endometrial-myometrial junction (EMJ) connects the endometrium and myometri…

preprint 2024
·doi:10.21203/rs.3.rs-3961335/v1
article 2024
International immunopharmacology ·doi:10.1016/j.intimp.2024.112366
article 2023
JAMA network open ·doi:10.1001/jamanetworkopen.2023.17860

Importance: Adenomyosis is a common chronic gynecological disorder, and its treatment is an unmet need. New therapies need to be developed. Mifepristone is being tested for adenomyosis treatment. Objective: To determine whether mifepristone…

article 2021
·doi:10.2139/ssrn.3897694
article 2021
Journal of cellular and molecular medicine ·doi:10.1111/jcmm.16261

Endometriosis is a benign, chronic inflammatory disease that commonly occurs in reproductive-aged women. Epithelial-mesenchymal transition (EMT) of endometrial epithelial cells plays an important role in the development of endometriosis. Re…

article 2020
International journal of medical sciences ·doi:10.7150/ijms.39252

Background: Adenomyosis is a quite common gynecological disorder and above 30% of patients have typical secondary and progressive dysmenorrhea. Current treatments still have many disadvantages and thereby the novel treatment aiming to relie…

article 2019
Journal of cellular and molecular medicine ·doi:10.1111/jcmm.14866

Adenomyosis is also called internal endometriosis and affects about 20% of reproductive-aged women. It seriously reduces life quality of patients because current drug therapies face with numerous challenges. Long-term clinical application o…

article 2019
Journal of pain research ·doi:10.2147/jpr.s205561

Purpose: Studies have shown that adenomyomectomy can effectively treat women with adenomyosis in a short period of time. However, the long-term efficacy of adenomyomectomy has rarely been reported. The objective of this study was to determi…

article 2014
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2014.01.027
article 2012
Acta histochemica ·doi:10.1016/j.acthis.2012.08.006
article 2012

Angiogenesis is a prerequisite for the formation and development of endometriosis. Pigment epithelium derived factor (PEDF) is a natural inhibitor of angiogenesis. We previously demonstrated a reduction of PEDF in the peritoneal fluid, seru…

article 2012
PloS one ·doi:10.1371/journal.pone.0045223

Angiogenesis is a prerequisite for the formation and development of endometriosis. Pigment epithelium derived factor (PEDF) is a natural inhibitor of angiogenesis. We previously demonstrated a reduction of PEDF in the peritoneal fluid, seru…